Market News
Stay updated with the latest market trends, earnings, and economic indicators.
Zydus Lifesciences shares gain nearly 7% on strong US growth outlook; Check price targets
Zydus' specialty pipeline remains the key focus with Desidustat in China, Saroglitazar and Nufymco launches in the US. The management said the specialty business is expected to see a meaningful ramp-up from FY28 onwards.
Zydus LifeSciences Shares in Focus: Motilal Oswal Maintains Neutral Rating on Limited Upside — Check Revised Target Price
The current valuation provides limited upside and hence, Motilal Oswal has maintained Neutral rating on Zydus Lifesciences.
Bharat Electronics, BPCL, Mankind Pharma, Zee Entertainment, Zydus Lifesciences Q4 Results Today — Earning Estimates
BPCL is expected to report March-quarter earnings with standalone revenue at Rs 1,17,692.16 crore.
Stocks to watch: HAL, IRFC, Bharti Airtel, Zydus Lifesciences among 10 shares in focus today - Mint
Stocks to watch: HAL, IRFC, Bharti Airtel, Zydus Lifesciences among 10 shares in focus todayMint
Here's why today and May 19 are important sessions for Zydus Life shareholders
Zydus Lifesciences will acquire Assertio Holdings for $23.5 per share in cash, valuing the transaction at $166.4 million. Assertio is a US-based specialty pharmaceutical company with a focus on oncology and pain management.
Stocks in news: HAL, TMPV, Bharti Airtel, Anant Raj, Zydus Life, Tata Motors
Indian markets experienced a volatile yet stable session after a sharp sell-off, with the Nifty showing resilience. Key companies like HAL, Tata Motors, and Bharti Airtel are in focus due to quarterly results and news developments. Zydus Lifesciences is nearing a US acquisition, while Maruti Suzuki commits to green logistics.
Zydus Lifesciences in focus after USFDA clears Ahmedabad plant, Aflibercept biosimilar launch
Zydus Lifesciences is in focus after receiving USFDA clearance with zero observations for its Ahmedabad facility and launching ANYRA, India’s first indigenous Aflibercept biosimilar. The developments strengthen its regulatory standing and expand its ophthalmology portfolio, positioning the company to tap into a large and growing domestic market for retinal therapies.
Momentum Stocks: Kalyan Jewellers, Sterlite Technologies, Usha Financial see negative breakdowns
Cemindia Projects, Titan Company, Gland Pharma, Granules India, Zydus Lifesciences, GMR Airports, JB Chemicals & Pharmaceuticals, Torrent Pharmaceuticals, among others hit 52-week high.
Stocks to Watch Today: Tata Motors, Andhra Cements, Sun Pharma, GMDC, Axiscades, Power Mech, Zydus Lifesciences, Bajaj Electricals in focus on 17 March
Stocks to Watch, 17 March: Stocks like Reliance Industries, Tata Motors, Andhra Cements, Sun Pharmaceutical Industries, Rail Vikas Nigam, Gujarat Mineral Development Corporation, Axiscades Technologies, Power Mech Projects, Redington, and Zydus Lifesciences will be in focus on March 17.
Trade Spotlight: How should you trade AGI Infra, Zydus Lifesciences, Crompton Greaves, KIMS, Nazara Technologies, and others on May 18?
The market needs to deliver a sustainable close above the previous day's high for the upward journey. Below are some short-term trading ideas to consider.
Stocks to Watch Today: Kotak Bank, Torrent Power, Persistent, Aurobindo Pharma, Dr Reddys Labs, KEC International, Turtlemint, Transrail, Airtel in focus on 29 June
Stocks to Watch, 29 Jun: Stocks like Kotak Mahindra Bank, Torrent Power, Persistent Systems, Aurobindo Pharma, Indoco Remedies, BEML, Lupin, Dr Reddys Laboratories, Jubilant Pharmova, Zydus Lifesciences, Hexaware Technologies, KEC International, Bharti Airtel, and Vodafone Idea will be in focus on June 29.